Researchers validate new radiolabeled molecule used in imaging tests to detect brain injury – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Oct 22 2020
Researchers have validated a new radiolabeled molecule that can be used with imaging tests to accurately detect and characterize brain injury. The team, led by investigators at Massachusetts General Hospital (MGH), recently received clearance from the U.S. Food and Drug Administration (FDA) to initiate a first-in-human study with the strategy.
As described in the Journal of Cerebral Blood Flow & Metabolism, the novel tracer, called

Click here to view the original article.